Oxford Nanopore Technologies (LON:ONT) Trading Down 14.3% - Here's What Happened

Oxford Nanopore Technologies plc (LON:ONT) experienced a notable decline of 14.3% during trading on Tuesday. The company’s stock reached a low of GBX 89.30 ($1.14) before closing slightly higher at GBX 90.10 ($1.15). Overall, approximately 50,400,641 shares changed hands, which represents a significant increase of 478% from the company's average daily trading volume of 8,719,918 shares. This downturn follows a previous closing price of GBX 105.10 ($1.34).

Wall Street Analyst Insights

In a separate note, analysts at JPMorgan Chase & Co. reaffirmed an "overweight" rating on Oxford Nanopore Technologies shares as of December 6th. Currently, five investment analysts have given the stock a buy rating. According to MarketBeat, it maintains an overall buy rating along with an average price target of GBX 235.50 ($3.01).

Stock Performance Analysis

With a market cap of £855.09 million, Oxford Nanopore Technologies holds a price-to-earnings ratio of -4.85, indicating losses. The beta of the stock is 0.80, showing reduced volatility compared to the market. Its fifty-day simple moving average stands at GBX 132.94, while the two-hundred-day simple moving average is GBX 138.65. The company’s financial ratios reveal a debt-to-equity ratio of 8.07, a current ratio of 4.45, and a quick ratio of 6.01, suggesting it has a solid liquidity position.

The last earnings report from Oxford Nanopore Technologies was disclosed on March 4th, where the company reported a loss of GBX (16) (($0.20)) per share for the quarter. The firm also indicated a negative return on equity of 26.02% and an alarming negative net margin of 94.82%.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies aims to offer the greatest societal benefits by enabling the analysis of anything, by anyone, anywhere.

Investment Considerations

Before deciding to invest in Oxford Nanopore Technologies, it is essential to analyze market trends and other investment opportunities. Although the company currently enjoys a buy rating from analysts, there are five other stocks deemed more attractive recommendations based on current market insights.

Stock, Analysts, Market